Tissue-specific effects of the nuclear factor κB subunit p50 on myocardial ischemia-reperfusion injury

American Journal of Pathology

Volumn 171, Issue 2, 2007, Pages 507-512

  Frantz, Stefan ^a,c   Tillmanns, Jochen ^a   Kuhlencordt, Peter J ^a   Schmidt, Isabel ^a   Adamek, Anna ^a   Dienesch, Charlotte ^a   Thum, Thomas ^a   Gerondakis, Steve ^b   Ertl, Georg ^a   Bauersachs, Johann ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; NUCLEAR FACTOR KAPPA B SUBUNIT P50; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; GEL MOBILITY SHIFT ASSAY; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; KNOCKOUT MOUSE; LEUKOCYTE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; TISSUE SPECIFICITY; UPREGULATION; WILD TYPE;

EID: 34547527483     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.061042     Document Type: Article

References (32)

1. Frantz S, Bauersachs J, Kelly RA: Innate immunity and the heart. Curr Pharm Des 2005, 11:1279-1290
2. Pahl HL: Activators and target genes of Rel/NF-κB transcription factors. Oncogene 1999, 18:6853-6866
3. Morgan EN, Boyle Jr EM, Yun W, Griscavage-Ennis JM, Farr AL, Canty Jr TG, Pohlman TH, Verrier ED: An essential role for NF-κB in the cardioadaptive response to ischemia. Ann Thorac Surg 1999, 68:377-382
4. Chandrasekar B, Freeman GL: Induction of nuclear factor κB and activation protein 1 in postischemic myocardium. FEBS Lett 1997, 401:30-34
5. Chatterjee PK, Patel NS, Cuzzocrea S, Brown PA, Stewart KN, Mota-Filipe H, Britti D, Eberhardt W, Pfeilschifter J, Thiemermann C: The cyclopentenone prostaglandin 15-deoxy-Δ(12,14)-prostaglandin J2 ameliorates ischemic acute renal failure. Cardiovasc Res 2004, 61:630-643
6. Norman DA, Yacoub MH, Barton PJ: Nuclear factor NF-κB in myocardium: developmental expression of subunits and activation by interleukin-1β in cardiac myocytes in vitro. Cardiovasc Res 1998, 39:434-441
7. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D: Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 1995, 376:167-170
8. Sha WC, Liou HC, Tuomanen El, Baltimore D: Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 1995, 80:321-330
9. Weih F, Caamano J: Regulation of secondary lymphoid organ development by the nuclear factor-κB signal transduction pathway, Immunol Rev 2003. 195:91-105
10. Tomczak MF, Erdman SE, Davidson A, Wang YY, Nambiar PR, Rogers AB, Rickman B, Luchetti D, Fox JG, Horwitz BH: Inhibition of Helicobacter hepaticus-induced colitis by IL-10 requires the p50/ p105 subunit of NF-κB. J Immunol 2006, 177:7332-7339
11. Mabley JG, Hasko G, Liaudet L, Soriano F, Southan GJ, Salzman AL, Szabo C: NFκB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes. J Endocrinol 2002, 173:457-464
12. Kanters E, Gijbels MJ, van der Made I, Vergouwe MN, Heeringa P, Kraal G, Hofker MH, de Winther MP: Hematopoietic NF-κB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype. Blood 2004, 103:934-940
13. Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, Schwaninger M: NF-κB is activated and promotes cell death in focal cerebral ischemia. Nat Med 1999, 5:554-559
14. Frantz S, Calvillo L, Tillmanns J, Elbing I, Dienesch C, Bischoff H, Ertl G, Bauersachs J: Repetitive postprandial hyperglycemia increases cardiac ischemia/reperfusion injury. Prevention by the α-glucosidase inhibitor Acarbose. FASEB J 2005, 19:591-593
15. Calvillo L, Masson S, Salio M, Pollicino L, De Angelis N, Fiordaliso F, Bai A, Ghezzi P, Santangelo F, Latini R: In vivo cardioprotection by N-acetylcysteine and isosorbide 5-mononitrate in a rat model of ischemia-reperfusion. Cardiovasc Drugs Ther 2003, 17:199-208
16. Frantz S, Hu K, Widder J, Bayer B, Witzel CC, Schmidt I, Galuppo P, Strotmann J, Ertl G, Bauersachs J: Peroxisome proliferator activated-receptor agonism and left ventricular remodeling in mice with chronic myocardial infarction. Br J Pharmacol 2004, 141:9-14
17. Frantz S, Kobzik L, Kim YD, Fukazawa R, Medzhitov R, Lee RT, Kelly RA: Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 1999, 104:271-280
18. Frantz S, Kelly RA, Bourcier T: Role of TLR-2 in the activation of nuclear factor-κB by oxidative stress in cardiac myocytes. J Biol Chem 2001, 276:5197-5203
19. Min/+ mouse model of intestinal tumorigenesis. Blood 2004, 103:1050-1058
20. Ritchie ME: Nuclear factor-κB is selectively and markedly activated in humans with unstable angina pectoris. Circulation 1998, 98:1707-1713
21. Frantz S, Hu K, Bayer B, Gerondakis S, Strotmann J, Adamek A, Ertl G, Bauersachs J: Absence of NF-κB subunit p50 improves heart failure after myocardial infarction. FASEB J 2006, 20:1918-1920
22. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, Ogihara T: In vivo transfection of cis element "decoy" against nuclear factor-κB binding site prevents myocardial infarction. Nat Med 1997, 3:894-899
23. Onai Y, Suzuki J, Kakuta T, Maejima Y, Haraguchi G, Fukasawa H, Muto S, Itai A, Isobe M: Inhibition of IκB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury. Cardiovasc Res 2004, 63:51-59
24. Tanaka M, Fuentes ME, Yamaguchi K, Durnin MH, Dalrymple SA, Hardy KL, Goeddel DV: Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice. Immunity 1999, 10:421-429
25. Vinten-Johansen J: Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 2004, 61:481-497
26. Squadrito F, Deodato B, Squadrito G, Seminara P, Passaniti M, Venuti FS, Giacca M, Minutoli L, Adamo EB, Bellomo M, Marini R, Galeano M, Marini H, Altavilla D: Gene transfer of IκBα limits infarct size in a mouse model of myocardial ischemia-reperfusion injury. Lab Invest 2003, 83:1097-1104
27. Kawamura N, Kubota T, Kawano S, Monden Y, Feldman AM, Tsutsui H, Takeshita A, Sunagawa K: Blockade of NF-κB improves cardiac function and survival without affecting inflammation in TNF-α-induced cardiomyopathy. Cardiovasc Res 2005, 66:520-529
28. Kawano S, Kubota T, Monden Y, Kawamura N, Tsutsui H, Takeshita A, Sunagawa K: Blockade of NF-κB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II. Cardiovasc Res 2005, 67:689-698
29. Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA: Possible new role for NF-κB in the resolution of inflammation. Nat Med 2001, 7:1291-1297
30. Chandrasekar B, Smith JB, Freeman GL: Ischemia-reperfusion of rat myocardium activates nuclear factor-κB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation 2001, 103:2296-2302
31. Hilliard B, Samoilova EB, Liu TS, Rostami A, Chen Y: Experimental autoimmune encephalomyelitis in NF-κB-deficient mice:roles of NF-κB in the activation and differentiation of autoreactive T cells. J Immunol 1999, 163:2937-2943
32. + T lymphocytes. Circulation 2006, 114:2056-2064